Betamethasone Sodium Phosphate 6 mg/mL P Injection, Betamethasone Sodium Phosphate 6 mg/mL PF I...

FDA Recall #D-113-2013 — Class II — September 26, 2012

Recall #D-113-2013 Date: September 26, 2012 Classification: Class II Status: Terminated

Product Description

Betamethasone Sodium Phosphate 6 mg/mL P Injection, Betamethasone Sodium Phosphate 6 mg/mL PF Injection, Betamethasone Sodium Phosphate 8 mg/mL PF Injection, Betamethasone Sodium Phosphate 12 mg/mL PF Injection, manufactured by New England Compounding Center, Framingham, MA

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

New England Compounding Center — Framingham, MA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

N/A

Distribution

Nationwide

Code Information

All lot codes

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated